home / stock / enscw / enscw quote
Last: | $0.0339 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0339 |
Close: | $0.0339 |
High: | $0.0339 |
Low: | $0.0339 |
Volume: | 100 |
Last Trade Date Time: | 07/15/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0339 | $0.0339 | $0.0339 | $0.0339 | $0.0339 | 100 | 07-15-2024 |
$0.020675 | $0.024 | $0.020675 | $0.024 | $0.0165 | 38,774 | 07-12-2024 |
$0.0344 | $0.0344 | $0.0344 | $0.0344 | $0.0344 | 2,600 | 07-11-2024 |
$0.0345 | $0.0345 | $0.0345 | $0.0345 | $0.0345 | 6,897 | 07-10-2024 |
$0.027805 | $0.0347 | $0.027805 | $0.0347 | $0.027805 | 1,100 | 07-09-2024 |
$0.0347 | $0.015 | $0.0347 | $0.0347 | $0.015 | 602 | 07-08-2024 |
$0.0347 | $0.0347 | $0.0347 | $0.0347 | $0.0347 | 100 | 07-05-2024 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 10,000 | 07-04-2024 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 10,000 | 07-03-2024 |
$0.025 | $0.0349 | $0.025 | $0.0349 | $0.025 | 4,000 | 07-02-2024 |
$0.0251 | $0.02755 | $0.0251 | $0.02755 | $0.0251 | 28,000 | 07-01-2024 |
$0.03147 | $0.035 | $0.03147 | $0.035 | $0.03147 | 400 | 06-28-2024 |
$0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 34,394 | 06-27-2024 |
$0.025 | $0.025 | $0.025 | $0.025 | $0.025 | 100 | 06-26-2024 |
$0.0354 | $0.0354 | $0.0354 | $0.0354 | $0.0354 | 706 | 06-25-2024 |
$0.0356 | $0.0356 | $0.0356 | $0.0356 | $0.0356 | 3,700 | 06-21-2024 |
$0.0359 | $0.028815 | $0.0359 | $0.0359 | $0.028815 | 4,600 | 06-20-2024 |
$0.0359 | $0.0359 | $0.0359 | $0.0359 | $0.0359 | 100 | 06-17-2024 |
$0.022 | $0.022 | $0.022 | $0.022 | $0.022 | 9,202 | 06-14-2024 |
$0.0102 | $0.0168 | $0.0102 | $0.0168 | $0.0102 | 55,000 | 06-13-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc Warrants (05/12/2019) Company Name:
ENSCW Stock Symbol:
OTCMKTS Market:
Ensysce Biosciences Inc Warrants (05/12/2019) Website:
~ Dr. Lynn Kirkpatrick, CEO, to Introduce Satellite Symposium on Severe Pain: A New Chapter for Safer Analgesics ~ SAN DIEGO, CA / ACCESSWIRE / July 9, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative ...
~ Collaboration with Purisys Positions Ensysce to Expedite Lead OUD Candidate, PF9001, to IND Studies ~ SAN DIEGO, CA / ACCESSWIRE / June 25, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions ...
~ Selects Lead Candidate with Abuse Deterrence and Improved Safety Profile to Treat Opioid Use Disorder ~ SAN DIEGO, CA / ACCESSWIRE / June 6, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions...